CLINICAL_TRIALS
trial_result
· 2014-03-05
Clinical Trial Update: Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain [Phase 3]
Summary
Phase 3 clinical trial update for fentanyl sublingual spray in treating breakthrough cancer pain. The trial has completed and results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: INSYS Therapeutics Inc | Conditions: Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-03-05